Clinical Trials Directory

Trials / Completed

CompletedNCT03505567

Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100

Pilot Comparative Study of the Kowa OCT Bi-μ and the Optovue iVue 100

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Kowa Research Institute, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is a prospective comparative study to gather pilot agreement and precision data in normal subjects, subjects with glaucoma, and subjects with retinal disease.

Conditions

Interventions

TypeNameDescription
DEVICEKOWA OCT Bi-µNon-contact, ultra-high resolution ophthalmic imaging system for fundus imaging and axial cross-sectional and three-dimensional imaging of retinal structures.
DEVICEOptovue iVue 100U.S. Food and Drug Administration (FDA) cleared and commercially available Optovue iVue 100

Timeline

Start date
2018-04-21
Primary completion
2018-09-01
Completion
2018-09-01
First posted
2018-04-23
Last updated
2018-09-10

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03505567. Inclusion in this directory is not an endorsement.

Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100 (NCT03505567) · Clinical Trials Directory